Cargando…

MEDB-03. Medulloblastoma cerebrospinal fluid reveals hypoxic indicators (metabolites and lipids) and cancer-specific RNAs

Medulloblastoma (MB) is the most common malignant brain tumor in children. There remains an unmet need for diagnostics to sensitively detect the disease, particularly recurrences. Cerebrospinal fluid (CSF) provides a window into the central nervous system, and liquid biopsy of CSF could provide a re...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Bongyong, Mohamad, Iqbal, Pokhrel, Rudramani, Murad, Rabi, Yuan, Menglang, Stapleton, Stacie, Bettegowda, Chetan, Jallo, George, Eberhart, Charles G, Garrett, Timothy, Perera, Ranjan J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9165113/
http://dx.doi.org/10.1093/neuonc/noac079.378
_version_ 1784720310812016640
author Lee, Bongyong
Mohamad, Iqbal
Pokhrel, Rudramani
Murad, Rabi
Yuan, Menglang
Stapleton, Stacie
Bettegowda, Chetan
Jallo, George
Eberhart, Charles G
Garrett, Timothy
Perera, Ranjan J
author_facet Lee, Bongyong
Mohamad, Iqbal
Pokhrel, Rudramani
Murad, Rabi
Yuan, Menglang
Stapleton, Stacie
Bettegowda, Chetan
Jallo, George
Eberhart, Charles G
Garrett, Timothy
Perera, Ranjan J
author_sort Lee, Bongyong
collection PubMed
description Medulloblastoma (MB) is the most common malignant brain tumor in children. There remains an unmet need for diagnostics to sensitively detect the disease, particularly recurrences. Cerebrospinal fluid (CSF) provides a window into the central nervous system, and liquid biopsy of CSF could provide a relatively non-invasive means for disease diagnosis. There has yet to be an integrated analysis of the transcriptomic, metabolomic, and lipidomic changes occurring in the CSF of children with MB. CSF samples from patients with (n=40) or without (n=11; no cancer) MB were subjected to RNA-sequencing and high-resolution mass spectrometry to identify RNA, metabolite, and lipid profiles. Differentially expressed transcripts, metabolites, and lipids were identified and their biological significance assessed by pathway analysis. Multivariate analysis method DIABLO (R package mixOmics) was used to integrate the molecular changes characterizing the CSF of MB patients. Differentially expressed transcripts, metabolites, and lipids in CSF were discriminatory for the presence of MB but not the exact molecular subtype. One hundred ten genes and ten circular RNAs were differentially expressed in MB CSF compared to normal representing TGF-β signaling, TNF-a signaling via NF-kB, and adipogenesis pathways. Tricarboxylic acid cycle and other metabolites (malate, fumarate, succinate, α-ketoglutarate, hydroxypyruvate, N-acetyl-aspartate) and total triacylglycerols were significantly upregulated in MB CSF compared to normal CSF. Although the transcriptomic, metabolomic, and lipid signatures in CSF to differentiate MB subgroup separation was challenging, we were able to identify a group of omics signatures that could separate cancer from normal CSF. Metabolic and lipidomic profiles both contained indicators of tumor hypoxia. Our approach provides several candidate signatures that deserve further validation, including the novel circular RNA circ_463, and insights into the impact of MB on the CSF microenvironment.
format Online
Article
Text
id pubmed-9165113
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-91651132022-06-05 MEDB-03. Medulloblastoma cerebrospinal fluid reveals hypoxic indicators (metabolites and lipids) and cancer-specific RNAs Lee, Bongyong Mohamad, Iqbal Pokhrel, Rudramani Murad, Rabi Yuan, Menglang Stapleton, Stacie Bettegowda, Chetan Jallo, George Eberhart, Charles G Garrett, Timothy Perera, Ranjan J Neuro Oncol Medulloblastoma Medulloblastoma (MB) is the most common malignant brain tumor in children. There remains an unmet need for diagnostics to sensitively detect the disease, particularly recurrences. Cerebrospinal fluid (CSF) provides a window into the central nervous system, and liquid biopsy of CSF could provide a relatively non-invasive means for disease diagnosis. There has yet to be an integrated analysis of the transcriptomic, metabolomic, and lipidomic changes occurring in the CSF of children with MB. CSF samples from patients with (n=40) or without (n=11; no cancer) MB were subjected to RNA-sequencing and high-resolution mass spectrometry to identify RNA, metabolite, and lipid profiles. Differentially expressed transcripts, metabolites, and lipids were identified and their biological significance assessed by pathway analysis. Multivariate analysis method DIABLO (R package mixOmics) was used to integrate the molecular changes characterizing the CSF of MB patients. Differentially expressed transcripts, metabolites, and lipids in CSF were discriminatory for the presence of MB but not the exact molecular subtype. One hundred ten genes and ten circular RNAs were differentially expressed in MB CSF compared to normal representing TGF-β signaling, TNF-a signaling via NF-kB, and adipogenesis pathways. Tricarboxylic acid cycle and other metabolites (malate, fumarate, succinate, α-ketoglutarate, hydroxypyruvate, N-acetyl-aspartate) and total triacylglycerols were significantly upregulated in MB CSF compared to normal CSF. Although the transcriptomic, metabolomic, and lipid signatures in CSF to differentiate MB subgroup separation was challenging, we were able to identify a group of omics signatures that could separate cancer from normal CSF. Metabolic and lipidomic profiles both contained indicators of tumor hypoxia. Our approach provides several candidate signatures that deserve further validation, including the novel circular RNA circ_463, and insights into the impact of MB on the CSF microenvironment. Oxford University Press 2022-06-03 /pmc/articles/PMC9165113/ http://dx.doi.org/10.1093/neuonc/noac079.378 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Medulloblastoma
Lee, Bongyong
Mohamad, Iqbal
Pokhrel, Rudramani
Murad, Rabi
Yuan, Menglang
Stapleton, Stacie
Bettegowda, Chetan
Jallo, George
Eberhart, Charles G
Garrett, Timothy
Perera, Ranjan J
MEDB-03. Medulloblastoma cerebrospinal fluid reveals hypoxic indicators (metabolites and lipids) and cancer-specific RNAs
title MEDB-03. Medulloblastoma cerebrospinal fluid reveals hypoxic indicators (metabolites and lipids) and cancer-specific RNAs
title_full MEDB-03. Medulloblastoma cerebrospinal fluid reveals hypoxic indicators (metabolites and lipids) and cancer-specific RNAs
title_fullStr MEDB-03. Medulloblastoma cerebrospinal fluid reveals hypoxic indicators (metabolites and lipids) and cancer-specific RNAs
title_full_unstemmed MEDB-03. Medulloblastoma cerebrospinal fluid reveals hypoxic indicators (metabolites and lipids) and cancer-specific RNAs
title_short MEDB-03. Medulloblastoma cerebrospinal fluid reveals hypoxic indicators (metabolites and lipids) and cancer-specific RNAs
title_sort medb-03. medulloblastoma cerebrospinal fluid reveals hypoxic indicators (metabolites and lipids) and cancer-specific rnas
topic Medulloblastoma
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9165113/
http://dx.doi.org/10.1093/neuonc/noac079.378
work_keys_str_mv AT leebongyong medb03medulloblastomacerebrospinalfluidrevealshypoxicindicatorsmetabolitesandlipidsandcancerspecificrnas
AT mohamadiqbal medb03medulloblastomacerebrospinalfluidrevealshypoxicindicatorsmetabolitesandlipidsandcancerspecificrnas
AT pokhrelrudramani medb03medulloblastomacerebrospinalfluidrevealshypoxicindicatorsmetabolitesandlipidsandcancerspecificrnas
AT muradrabi medb03medulloblastomacerebrospinalfluidrevealshypoxicindicatorsmetabolitesandlipidsandcancerspecificrnas
AT yuanmenglang medb03medulloblastomacerebrospinalfluidrevealshypoxicindicatorsmetabolitesandlipidsandcancerspecificrnas
AT stapletonstacie medb03medulloblastomacerebrospinalfluidrevealshypoxicindicatorsmetabolitesandlipidsandcancerspecificrnas
AT bettegowdachetan medb03medulloblastomacerebrospinalfluidrevealshypoxicindicatorsmetabolitesandlipidsandcancerspecificrnas
AT jallogeorge medb03medulloblastomacerebrospinalfluidrevealshypoxicindicatorsmetabolitesandlipidsandcancerspecificrnas
AT eberhartcharlesg medb03medulloblastomacerebrospinalfluidrevealshypoxicindicatorsmetabolitesandlipidsandcancerspecificrnas
AT garretttimothy medb03medulloblastomacerebrospinalfluidrevealshypoxicindicatorsmetabolitesandlipidsandcancerspecificrnas
AT pereraranjanj medb03medulloblastomacerebrospinalfluidrevealshypoxicindicatorsmetabolitesandlipidsandcancerspecificrnas